# Evaluation of Obstetrical and Neonatal Complications in Hereditary Haemorrhagic Telangiectasia (HHT)

> **NCT03691142** · — · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 207 (actual)

## Conditions studied

- Osler Rendu Disease
- Hereditary Hemorrhagic Telangiectasia

## Interventions

- **OTHER:** Questionnaire

## Key facts

- **NCT ID:** NCT03691142
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-02
- **Primary completion:** 2019-10-02
- **Final completion:** 2019-10-02
- **Target enrollment:** 207 (ACTUAL)
- **Last updated:** 2019-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03691142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03691142, "Evaluation of Obstetrical and Neonatal Complications in Hereditary Haemorrhagic Telangiectasia (HHT)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03691142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*